- Patent Title: Hematopoietic cell phenotyping using circulating cell-free markers
-
Application No.: US14992505Application Date: 2016-01-11
-
Publication No.: US10067133B2Publication Date: 2018-09-04
- Inventor: Maher Albitar
- Applicant: Quest Diagnostics Investments Incorporated
- Applicant Address: US DE Wilmington
- Assignee: Quest Diagnostics Investments Incorporated
- Current Assignee: Quest Diagnostics Investments Incorporated
- Current Assignee Address: US DE Wilmington
- Agency: Foley & Lardner LLP
- Main IPC: G01N33/574
- IPC: G01N33/574 ; G01N33/68
Abstract:
The present invention provides methods of classifying cluster of differentiation (CD) marker phenotype for hematopoietic cancer cells using multiple circulating cell-free CD markers in bodily fluid. In other aspects, treatment and disease progression of particular hematopoietic cancers can be monitored by measuring the levels of CD and other markers in bodily fluids of a patient.
Public/Granted literature
- US20160123985A1 HEMATOPOIETIC CELL PHENOTYPING USING CIRCULATING CELL-FREE MARKERS Public/Granted day:2016-05-05
Information query
IPC分类:
